- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00380471
Treatment and Complication of Bath PUVA in Vitiligo
January 22, 2008 updated by: Shahid Beheshti University of Medical Sciences
The purpose of this study is to determine whether bath PUVA are effective in treatment of vitiligo and what is the complication of bath PUVA in vitiligo.
Study Overview
Study Type
Interventional
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tehran, Iran, Islamic Republic of, 19899
- Recruiting
- Skin Research Center, Shaheed Beheshti Medical University
-
Contact:
- Parviz Toossi, M.D.
- Phone Number: 98-21-22744392
- Email: src@sbmu.ac.ir
-
Principal Investigator:
- Parviz Toossi, M.D.
-
Sub-Investigator:
- Fatemeh Aryanejad, MD
-
Sub-Investigator:
- Gita Meshkat Razavi, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Vitiligo
Exclusion Criteria:
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Parviz Toossi, M.D., Shahid Beheshti University of Medical Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2006
Primary Completion
December 7, 2022
Study Completion (Anticipated)
August 1, 2006
Study Registration Dates
First Submitted
September 25, 2006
First Submitted That Met QC Criteria
September 25, 2006
First Posted (Estimate)
September 26, 2006
Study Record Updates
Last Update Posted (Estimate)
January 23, 2008
Last Update Submitted That Met QC Criteria
January 22, 2008
Last Verified
January 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- src-pts-968
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitiligo
-
Kasr El Aini HospitalActive, not recruitingVitiligo VulgarisEgypt
-
Hudson BiotechRecruitingNonSegmental Vitiligo | Nonsegmental Vitiligo (Stable)China
-
Novartis PharmaceuticalsRecruitingNon-segmental VitiligoAustralia, United States, China, Japan, Canada
-
PfizerActive, not recruitingStable Nonsegmental Vitiligo | Active Nonsegmental VitiligoUnited States, Spain, China, Puerto Rico, Australia, Canada, Hungary, United Kingdom, Taiwan, Japan, Slovakia, Bulgaria, Germany, Belgium, Mexico, Italy, Poland, Turkey (Türkiye)
-
Centre Hospitalier Universitaire de NiceNot yet recruiting
-
PfizerCompletedStable Nonsegmental Vitiligo | Active Nonsegmental VitiligoUnited States, Spain, Australia, China, Germany, Canada, Japan, Italy, United Kingdom, South Africa, Mexico, Bulgaria, South Korea, Turkey (Türkiye), Poland
-
Sohag UniversityNot yet recruitingVitiligo - Macular Depigmentation
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingNon-segmental VitiligoChina
-
InventisBio Co., LtdNot yet recruitingVitiligo | Non-Segmental Vitiligo (NSV)China
-
Elixiron Immunotherapeutics (Hong Kong) Ltd.RecruitingNon-segmental VitiligoTaiwan, United States
Clinical Trials on Bath PUVA
-
Ruhr University of BochumTerminatedAtopic DermatitisGermany
-
Istanbul University - CerrahpasaCompletedInfant BehaviorTurkey
-
Afyonkarahisar Health Sciences UniversityRecruitingComplex Regional Pain Syndrome | Distal Radius Fracture | Complex Regional Pain Syndrome Type ITurkey
-
Paracelsus Harz Clinic Bad Suderode.Completed
-
The Affiliated Hospital of Putian UniversityNot yet recruiting
-
Nuh Naci Yazgan UniversityTC Erciyes UniversityCompletedVital | Blood Gases
-
Schweinhardt PetraRecruitingLow Back Pain | Compare Pain Modulation Assessments in Pain-free CohortsSwitzerland
-
Marmara UniversityNot yet recruiting
-
Hacettepe UniversityCompletedRheumatoid Arthritis - RheumatismTurkey
-
Ankara Etlik City HospitalCompletedDiabetic Distal Symmetric PolyneuropathyTurkey (Türkiye)